Adefovir Dipivoxil Tablets are indicated for the treatment of chronic hepatitis B in patients 12 years of age and older with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease.

Adefovir Dipivoxil Tablets
  • Compare to
    Hepsera®*
*Hepsera® is a registered trademark of Gilead Sciences, Inc.

Adefovir Dipivoxil Tablets (10 mg)

  • Package size
    30 ct
  • Rating
    AB
  • Strength
    10 mg
  • NDC Code
    42794-0003-08
Adefovir Dipivoxil Tablets (10 mg)

 

* Disclaimer: All images shown are for illustrative purposes only. Actual product may vary due to image enhancement. The images and information for a particular product may change over time. For the most up-to-date product information, please contact Sigmapharm Laboratories, LLC.